adrianmd92

A status of anticancer drug and nutraceutical delivery by cyclodextrin monomers and nanosponges

The COVID-19 pandemic masked the continuous growth of diseases such as cancer. Although the scientific community has studied these diseases

Recently the Francesco Trotta’s group of the University of Turin (Italy) has finalized and published the preliminar results that he

Authors: Monfared, Y.K and Matencio, A. University of Turin. Recently, prof. Francesco Trotta group of the University of Turin has

The 4-7 September 2022 in Ascea (Salerno, Italy) is the V International Summer School on Cyclodextrins, which welcomes graduate students,

The food industry is constantly increasing the number of functional foods in the market to satisfy our demands and, the

The considerable increase in of anticancer and antimicrobial drug resistance in the last years have created a difficult situation in

The usual thinking with cyclodextrin is about its capacity to complex small molecules, even there is a considerable bibliography about

Inflammation is one of the usual biological responses to different pathologies or stimuli. As the incidence of inflammation related diseases

Cyclodextrin (CD) are classicaly know to be an excellent drug carrier although applications as active drug have been studied (orphan

When you think of cyclodextrins, you think of their great applicability as a drug carrier. However, its role in food